FDA Adverse Event Injury Summary report: N

SHOULDER SYSTEM

MDR report key: 21197089 · Received January 21, 2025

Report

Report Number
3005180920-2024-01179
Event Type
Injury
Date Received
January 21, 2025
Date of Event
December 27, 2024
Report Date
November 14, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
PHX
UDI-DI
07630040706292
PMA / PMN Number
K170452
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

REASON FOR THE FOLLOW UP. ON 24.OCT.2025 THE COMPLAINT (B)(4) WAS NOTIFIED, AND WE DISCOVERED, A FEW DAYS LATER WITH SOME QUESTIONS, THAT THE PATIENT WAS INVOLVED IN THE COMPLAINT (B)(4). THE PATIENT, REVISED IN 2024, HAD THE SECOND STEP REVISION AS PART OF THE ORIGINAL TREATMENT PLAN FOLLOWING THE BONE GRAFT HEALING. THE SURGEON HAD PREVIOUSLY BONE GRAFTED THE GLENOID AND WAS WAITING FOR IT TO HEAL BEFORE HE COULD PERFORM THE REVERSE SHOULDER. THIS IS WHY HE CONVERTED THE PATIENT TO REVERSE. PRESENTLY, ON (B)(6) 2025, THE PATIENT CAME IN REPORTING PAIN AND THE CAUSE IS UNKNOWN. THE SURGEON CONVERTED THE MEDACTA HEMIARTHROPLASTY TO A REVERSE SHOULDER. THE SURGERY WAS COMPLETED SUCCESSFULLY. IMPLANTED: 04.01.0119 HUMERAL REVERSE HC LINER Ø36/+0MM 2414226 04.01.0110 HUMERAL REVERSE METAPHYSIS +0MM/0° 2434141.

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 30 DECEMBER 2024: LOT 173418: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 2017-07-03. EXPIRATION DATE: 2022-06-18. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD, NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. BATCH REVIEW PERFORMED ON 30 DECEMBER 2024: REVERSE SHOULDER SYSTEM 04.01.0110 HUMERAL REVERSE METAPHYSIS +0MM/0° (K170452) LOT 1905789: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 2019-10-31. EXPIRATION DATE: 2024-10-16. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD, NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. CLINICAL EVALUATION PERFORMED BY MEDACTA MEDICAL AFFAIRS MANAGER: REVISION SURGERY DONE DUE TO BREAKEAGE OF A SCREW AND THE LOOSENING OF THE GLENOSPHERE AND THE BASEPLATE WHICH ARE NOT FROM MEDACTA. THE ONLY PART FROM MEDACTA ARE THE LINER AND THE METAPHYSIS WHICH ARE NOT THE REASON OF THE REVISION. ROOT CAUSE: REVISION SURGERY DONE DUE TO BREAKEAGE OF A SCREW AND THE LOOSENING OF THE GLENOSPHERE AND THE BASEPLATE WHICH ARE NOT FROM MEDACTA. THE ONLY PART FROM MEDACTA ARE THE LINER AND THE METAPHYSIS WHICH ARE NOT THE REASON OF THE REVISION.

Description of Event or Problem · 0

REVISION SURGERY 4 YEARS AND 11 MONTHS AFTER THE PRIMARY SURGERY DUE TO NOT MEDACTA BASEPLATE LOOSENING, NOT MEDACTA SCREW BREAKAGE AND OSTEOLYSIS FOUND IN THE GLENOID PART. THE SURGEON CONVERTED THE PATIENT TO AN ANATOMIC SHOULDER. THE SURGERY WAS COMPLETED SUCCESSFULLY. LINER AND METAPHYSIS ARE THE ONLY MEDACTA PRODUCTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
555712 SHOULDER SYSTEM REVERSE SHOULDER SYSTEM HUMERAL REVERSE HC LINER Ø39/+0MM PHX MEDACTA INTERNATIONAL SA 04.01.0122 173418 07630040706292

Patients

Seq Age Sex Outcome Treatment
1 79 YR Female Required Intervention